Precursors / GlaxoSmithKline
GlaxoSmithKline
- Syntheses citing them
- 5
- Distinct agents
- 1
- Distinct precursors
- 2
From the literature
Precursors named in the literature
Names as written by the authors. Grade, packaging and current availability are not published and have to be confirmed with the supplier.
Where they were used
| Agent | Precursor | Module | Purification | Source |
|---|---|---|---|---|
| [131I]tositumomab | — | — | — | 24749780 2014 Br J Haematol |
| [131I]tositumomab | tositumomab | Kit-based preparation | — | 23875170 2013 Front Oncol |
| [131I]tositumomab | tositumomab immunoglobulin G2a [IgG2a] | Manual synthesis | — | 22955187 2012 Nucl Med Commun |
| [131I]tositumomab | — | Kit-based preparation | — | 21098795 2010 J Nucl Med |
| [131I]tositumomab | tositumomab | — | — | 19707321 2007 Biologics |
From the manufacturer
No manufacturer-submitted profile yet. Everything above comes from published papers, not from GlaxoSmithKline itself.
Need this precursor?We can point you to suppliers for GlaxoSmithKline, or handle the enquiry for you.
Get in touch